Liam S Acheson, Christopher Gordon, Rebecca McKetin, Jonathan Brett, Michael Christmass, Craig Rodgers, Nicholas Lintzeris, Adrian Dunlop, Michael Farrell, Steven Shoptaw, Nadine Ezard, Krista J Siefried
INTRODUCTION: Sleep disturbance is common during methamphetamine (MA) use and withdrawal; however, the feasibility of combined subjective-objective measurement of sleep-wake has not been shown in this population. Actigraphy is a well-established, non-invasive measure of sleep-wake cycles with good concordance with polysomnography. This study aimed to investigate the feasibility and utility of using actigraphy and sleep diaries to investigate sleep during MA withdrawal. METHODS: We conducted a feasibility and utility study of actigraphy and sleep diaries during a clinical trial of lisdexamfetamine for MA withdrawal...
March 18, 2024: European Addiction Research